{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T11:16:39Z","timestamp":1725880599848},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00101-023-01350-9","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T15:02:33Z","timestamp":1697554953000},"page":"799-802","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diabetes insipidus renalis nach inhalativer Sedierung mit Sevofluran bei einem Patienten mit COVID-19-assoziiertem akuten Lungenversagen","Nephrogenic diabetes insipidus after inhalation sedation with sevoflurane in a\u00a0patient with COVID-19-associated acute respiratory distress syndrome"],"prefix":"10.1007","volume":"72","author":[{"given":"Johannes","family":"Reins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Balling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Baader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elfriede","family":"B\u00f6ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Sch\u00f6niger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene","family":"van Erp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Eff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"1350_CR1","unstructured":"Kluge S, Janssens U, Welte T et al (2023) S3-Leitlinie Empfehlungen zur Therapie von Patienten mit COVID-19. (AWMF-Register-Nr. 113\/001)"},{"key":"1350_CR2","unstructured":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin (2017) S3-Leitlinie Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz. (AWMF-Register-Nr. 001\/021)"},{"key":"1350_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00101-009-1559-3","volume":"58","author":"M Lichtwarck-Aschoff","year":"2009","unstructured":"Lichtwarck-Aschoff\u00a0M, Dietrich\u00a0B, Breitschaft\u00a0D (2009) Disorders of water and sodium balance in intensive care patients. Anaesthesist 58:543\u2013560","journal-title":"Anaesthesist"},{"key":"1350_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13054-019-2594-3","volume":"23","author":"PM Honore","year":"2019","unstructured":"Honore\u00a0PM, De Bels\u00a0D, Barreto Gutierrez\u00a0L et\u00a0al (2019) Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue? Crit Care 23:304","journal-title":"Crit Care"},{"key":"1350_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41572-019-0103-2","volume":"5","author":"M Christ-Crain","year":"2019","unstructured":"Christ-Crain\u00a0M, Bichet\u00a0DG, Fenske\u00a0WK et al (2019) Diabetes insipidus. Nat Rev Dis Primers 5:54","journal-title":"Nat Rev Dis Primers"},{"key":"1350_CR6","doi-asserted-by":"publisher","first-page":"104093","DOI":"10.1016\/j.lpm.2021.104093","volume":"50","author":"M Christ-Crain","year":"2021","unstructured":"Christ-Crain\u00a0M, Gaisl\u00a0O (2021) Diabetes insipidus. Presse Med 50:104093","journal-title":"Presse Med"},{"key":"1350_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5114\/ait.2022.113950","volume":"54","author":"J Bansbach","year":"2022","unstructured":"Bansbach\u00a0J, Wenz\u00a0J, Kaufmann\u00a0K et al (2022) Sevoflurane in combination with esketamine is an effective sedation regimen in COVID-19\u00a0patients enabling assisted spontaneous breathing even during prone positioning. Anaesthesiol Intensive Ther 54:23\u201329","journal-title":"Anaesthesiol Intensive Ther"},{"key":"1350_CR8","doi-asserted-by":"publisher","first-page":"e0249889","DOI":"10.1371\/journal.pone.0249889","volume":"16","author":"R Blondonnet","year":"2021","unstructured":"Blondonnet\u00a0R, Quinson\u00a0A, Lambert\u00a0C et\u00a0al (2021) Use of volatile agents for sedation in the intensive care unit: A\u00a0national survey in France. PLoS ONE 16:e249889","journal-title":"PLoS ONE"},{"key":"1350_CR9","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1164\/rccm.201604-0686OC","volume":"195","author":"M Jabaudon","year":"2017","unstructured":"Jabaudon\u00a0M, Boucher\u00a0P, Imhoff\u00a0E et\u00a0al (2017) Sevoflurane for sedation in acute respiratory distress syndrome. A\u00a0randomized controlled pilot study. Am J Respir Crit Care Med 195:792\u2013800","journal-title":"Am J Respir Crit Care Med"},{"key":"1350_CR10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S2213-2600(21)00323-4","volume":"9","author":"A Meiser","year":"2021","unstructured":"Meiser\u00a0A, Volk\u00a0T, Wallenborn\u00a0J et al (2021) Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase\u00a03, randomised controlled, non-inferiority trial. Lancet Respir Med 9:1231\u20131240","journal-title":"Lancet Respir Med"},{"key":"1350_CR11","doi-asserted-by":"publisher","first-page":"e1246","DOI":"10.1097\/CCM.0000000000001956","volume":"44","author":"M Muyldermans","year":"2016","unstructured":"Muyldermans\u00a0M, Jennes\u00a0S, Morrison\u00a0S et al (2016) Partial Nephrogenic diabetes Insipidus in a\u00a0burned patient receiving Sevoflurane sedation with an anesthetic conserving device\u2011A case report. Crit Care Med 44:e1246\u2013e1250","journal-title":"Crit Care Med"},{"key":"1350_CR12","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.bja.2019.02.009","volume":"122","author":"M L\u2019heude","year":"2019","unstructured":"L\u2019heude\u00a0M, Poignant\u00a0S, Elaroussi\u00a0D et\u00a0al (2019) Nephrogenic diabetes insipidus associated with prolonged sedation with sevoflurane in the intensive care unit. Br J Anaesth 122:e73\u2013e75","journal-title":"Br J Anaesth"},{"key":"1350_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1213\/XAA.0000000000000871","volume":"12","author":"R Cabibel","year":"2019","unstructured":"Cabibel\u00a0R, Gerard\u00a0L, Maiter\u00a0D et\u00a0al (2019) Complete Nephrogenic diabetes Insipidus after prolonged Sevoflurane sedation: a\u00a0case report of 3 cases. A\u00a0A Pract 12:155\u2013159","journal-title":"A A Pract"},{"key":"1350_CR14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/EJA.0000000000001318","volume":"38","author":"S Coppola","year":"2021","unstructured":"Coppola\u00a0S, Cenci\u00a0S, Cozzolino\u00a0M et\u00a0al (2021) Sevoflurane sedation and nephrogenic diabetes insipidus in patients affected with severe acute respiratory syndrome coronavirus 2. Eur J Anaesthesiol 38:438\u2013441","journal-title":"Eur J Anaesthesiol"},{"key":"1350_CR15","first-page":"3312306","volume":"2022","author":"C Dupuis","year":"2022","unstructured":"Dupuis\u00a0C, Robert\u00a0A, Gerard\u00a0L et al (2022) Nephrogenic diabetes Insipidus following an off-label administration of Sevoflurane for prolonged sedation in a\u00a0COVID-19\u00a0patient and possible influence on Aquaporin\u20112 renal expression. Case Rep Anesthesiol 2022:3312306","journal-title":"Case Rep Anesthesiol"},{"key":"1350_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/bja\/83.5.734","volume":"83","author":"K Morita","year":"1999","unstructured":"Morita\u00a0K, Otsuka\u00a0F, Ogura\u00a0T et al (1999) Sevoflurane anaesthesia causes a\u00a0transient decrease in aquaporin\u20112 and impairment of urine concentration. Br J Anaesth 83:734\u2013739","journal-title":"Br J Anaesth"},{"key":"1350_CR17","first-page":"275","volume":"223","author":"GF Rush","year":"1982","unstructured":"Rush\u00a0GF, Willis\u00a0LR (1982) Renal tubular effects of sodium fluoride. J\u00a0Pharmacol Exp Ther 223:275\u2013279","journal-title":"J Pharmacol Exp Ther"},{"key":"1350_CR18","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.kint.2020.07.019","volume":"98","author":"A Werion","year":"2020","unstructured":"Werion\u00a0A, Belkhir\u00a0L, Perrot\u00a0M et al (2020) SARS-CoV\u20112 causes a\u00a0specific dysfunction of the kidney proximal tubule. Kidney Int 98:1296\u20131307","journal-title":"Kidney Int"},{"key":"1350_CR19","doi-asserted-by":"publisher","first-page":"e01295","DOI":"10.1213\/XAA.0000000000001295","volume":"14","author":"MA Zimmer","year":"2020","unstructured":"Zimmer\u00a0MA, Zink\u00a0AK, Wei\u00dfer\u00a0CW et al (2020) Hypernatremia\u2014A manifestation of COVID-19: a\u00a0case series. A\u00a0A Pract 14:e1295","journal-title":"A A Pract"},{"key":"1350_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bja.2022.02.031","volume":"129","author":"JR Sneyd","year":"2022","unstructured":"Sneyd\u00a0JR (2022) Avoiding kidney damage in ICU sedation with sevoflurane: use isoflurane instead. Br J Anaesth 129:7\u201310","journal-title":"Br J Anaesth"}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-023-01350-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-023-01350-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-023-01350-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:02:40Z","timestamp":1698656560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-023-01350-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1007\/s00101-023-01350-9","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"21 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Reins, F.\u00a0Balling, C.\u00a0Baader, E.\u00a0B\u00f6ck, W.\u00a0Sch\u00f6niger, R.\u00a0van Erp, S.\u00a0Eff und S.\u00a0Hafner geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}